[PDF][PDF] Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET
P Pietrini, GE Alexander, ML Furey, A Dani… - Journal of Nuclear …, 2000 - Soc Nuclear Med
Alzheimer'sdiseaseisassociatedwithreductionsinresting-state brainmetabolism,
asmeasuredbyPET, progressingwithdemen tia severity. The purposeof thisstudywas to see …
asmeasuredbyPET, progressingwithdemen tia severity. The purposeof thisstudywas to see …
Brain metabolism in the cerebellum and visual cortex correlates with neuropsychological testing in patients with Alzheimer's disease
A Newberg, A Cotter, M Udeshi… - Nuclear medicine …, 2003 - journals.lww.com
This study was designed to measure glucose metabolic deficits in areas not typically
recognized as abnormal on 18 F-fluorodeoxyglucose positron emission tomography (FDG …
recognized as abnormal on 18 F-fluorodeoxyglucose positron emission tomography (FDG …
Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer disease
R Duara, WW Barker, J Chang… - Journal of Cerebral …, 1992 - journals.sagepub.com
Twenty subjects with mildly to moderately severe Alzheimer disease (AD) and 14 normal
elderly control subjects were studied using [18F] fluorodeoxyglucose and positron emission …
elderly control subjects were studied using [18F] fluorodeoxyglucose and positron emission …
Association between cognitive performance and cortical glucose metabolism in patients with mild Alzheimer's disease
ALW Bokde, SJ Teipel, A Drzezga, J Thissen… - Dementia and geriatric …, 2005 - karger.com
Background: Neuronal and synaptic function in Alzheimer's disease (AD) is measured in
vivo by glucose metabolism using positron emission tomography (PET). Objective: We …
vivo by glucose metabolism using positron emission tomography (PET). Objective: We …
[PDF][PDF] Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET
M Kushner, M Tobin, A Alavi, J Chawluk… - Journal of Nuclear …, 1987 - Soc Nuclear Med
METHODS The study group included: unilateral cerebral infarction— 23 (mean age 65 yr,
range 47-80 yr), unilateral cerebral tumor— 23 (mean age 52 yr, range 37-71 yr) …
range 47-80 yr), unilateral cerebral tumor— 23 (mean age 52 yr, range 37-71 yr) …
Positron emission tomography in normal aging and Alzheimer's disease
SI Rapoport - Gerontology, 1986 - karger.com
Age differences are not found for the regional cerebral metabolic rate for glucose (rCMR glc)
measured with positron emission tomography (PET) with 18 F-2-deoxy-D-glucose, in healthy …
measured with positron emission tomography (PET) with 18 F-2-deoxy-D-glucose, in healthy …
Altered cerebral energy metabolism in Alzheimer's disease: a PET study.
H Fukuyama, M Ogawa, H Yamauchi… - Journal of nuclear …, 1994 - europepmc.org
Methods Nine patients with Alzheimer's disease and nine age-matched normal controls
were imaged using 18F-labeled deoxyglucose and 15O-labeled gases. Results Regional …
were imaged using 18F-labeled deoxyglucose and 15O-labeled gases. Results Regional …
Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study
P Pietrini, ML Furey, GE Alexander… - American Journal of …, 1999 - Am Psychiatric Assoc
OBJECTIVE: This study tested the hypothesis that regional cerebral glucose metabolism
during neuronal activation is a more sensitive index of neuronal dysfunction and clinical …
during neuronal activation is a more sensitive index of neuronal dysfunction and clinical …
Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by PET
K Ishii, H Kitagaki, M Kono… - The Journal of Nuclear …, 1996 - search.proquest.com
In mild-to-moderate Alzheimer's disease, previous PET studies failed to reveal significant
involvement in the medial temporal lobe having pathologically neurodegenerative changes …
involvement in the medial temporal lobe having pathologically neurodegenerative changes …
HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern
R Mielke, U Pietrzyk, A Jacobs, GR Fink… - European journal of …, 1994 - Springer
Positron emission tomography (PET) of 18 F-2-fluoro-2-shirlyD-glucose (FDG) and single-
photon emission tomography (SPET) of 99m Tc-hexamethyl-propylene amine oxime …
photon emission tomography (SPET) of 99m Tc-hexamethyl-propylene amine oxime …
Related searches
- healthy volunteers alzheimer's disease
- fdg pet alzheimer's disease
- metabolic pattern alzheimer's disease
- dementia severity alzheimer's disease
- glucose transport alzheimer's disease
- visual cortex alzheimer's disease
- hmpao spet alzheimer's disease
- neuropsychological testing alzheimer's disease
- comparison of perfusion alzheimer's disease
- normal aging alzheimer's disease
- fdg pet metabolic pattern
- brain metabolism alzheimer's disease
- vascular dementia alzheimer's disease
- oxygen metabolism alzheimer's disease
- energy metabolism alzheimer's disease